When does outsourcing autologous collection center qualification and the cell therapy supply chain make sense?
Amy Hines, Jeni Newman, Marcel van Houten
iPSC-based therapy dilemmas explored: overcoming hurdles for future success
L Munsie, K Raineri, M Carpenter et al
Empowering the future of cell therapy: leveraging partnerships to support advancement
J Patarroyo, F Mack, X de Mollerat du Jeu et al
How reducing labor time can save on your cell therapy manufacturing costs
Yen Kong, Jeeheon Kang, Janôt Schoep
Improve your speed to therapy and drive efficiency by integrating supply chain and manufacturing
Robert Lutskus, Matthew Lakelin
